Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Five modifiable risk factors are associated with cardiovascular disease and death from any cause. Studies using individual-level data to evaluate the regional and sex-specific prevalence of the risk factors and their effect on these outcomes are lacking. METHODS: We pooled and harmonized individual-level data from 112 cohort studies conducted in 34 countries and 8 geographic regions participating in the Global Cardiovascular Risk Consortium. We examined associations between the risk factors (body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking, and diabetes) and incident cardiovascular disease and death from any cause using Cox regression analyses, stratified according to geographic region, age, and sex. Population-attributable fractions were estimated for the 10-year incidence of cardiovascular disease and 10-year all-cause mortality. RESULTS: Among 1,518,028 participants (54.1% of whom were women) with a median age of 54.4 years, regional variations in the prevalence of the five modifiable risk factors were noted. Incident cardiovascular disease occurred in 80,596 participants during a median follow-up of 7.3 years (maximum, 47.3), and 177,369 participants died during a median follow-up of 8.7 years (maximum, 47.6). For all five risk factors combined, the aggregate global population-attributable fraction of the 10-year incidence of cardiovascular disease was 57.2% (95% confidence interval [CI], 52.4 to 62.1) among women and 52.6% (95% CI, 49.0 to 56.1) among men, and the corresponding values for 10-year all-cause mortality were 22.2% (95% CI, 16.8 to 27.5) and 19.1% (95% CI, 14.6 to 23.6). CONCLUSIONS: Harmonized individual-level data from a global cohort showed that 57.2% and 52.6% of cases of incident cardiovascular disease among women and men, respectively, and 22.2% and 19.1% of deaths from any cause among women and men, respectively, may be attributable to five modifiable risk factors. (Funded by the German Center for Cardiovascular Research (DZHK); ClinicalTrials.gov number, NCT05466825.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As well as the significant improvement in diabetic control, cardiometabolic risk was also improved by a significant reduction in SBP which was recorded across the cohort, specifically for those who had one or more co-existing medical conditions and for those who had a diagnosis of T2D of less than 6 years29.”
From mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes (2025) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138 · cited 1×
“Although very low non-HDL cholesterol concentrations are related to reduced CVD events, 25,26 some observations point towards higher all-cause mortality rates in individuals with very low levels at least in longer-term follow-up.”
(2010) · University of Twente Research Information · Cited by 6,037
Auditory and non-auditory effects of noise on health
Basner, M., Babisch, W., Davis, A., Brink, M., Clark, C., Janssen, S., & Stansfeld, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61613-x · Cited by 2,473 · cited 1×
“Environmental and exposomal factors such as physical activity 18 , alcohol consumption 28 , air pollution 29 , climate and noise 30 , educational level 3 or psychosocial risk factors including depression 31 impact CVD risk.”
Global burden of blood-pressure-related disease, 2001
Lawes, C. M., Hoorn, S. V., & Rodgers, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60655-8 · Cited by 2,330 · cited 3×
“While tobacco consumption is strongly associated with premature mortality, elevated blood pressure and cholesterol are more specifically related to CVD. 7 A tailored reduction in the burden of CVD and all-cause mortality for persons and populations can be achieved with better understanding of the region-and sex-specif…”
InfluentialEfficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Robinson, J. G., Farnier, M., Krempf, M., Bergeron, J., Luc, G., Averna, M., Stroes, E. S., Langslet, G., Raal, F. J., El Shahawy, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501031 · Cited by 2,296 · cited 1×
“Although very low non-HDL cholesterol concentrations are related to reduced CVD events, 25,26 some observations point towards higher all-cause mortality rates in individuals with very low levels at least in longer-term follow-up.”
The Global Burden of Cardiovascular Diseases and Risk
Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.005 · Cited by 2,217
Cited by
Items 501–600 of 980
Overlaps of risk factors between different cardiovascular phenotypes
Behrendt, C., Haack, A., Bay, B., Thomalla, G., Rimmele, D. L., Petersen, E. L., Blankenberg, S., Schnabel, R. B., Magnussen, C., Schäfer, I., et al. (2025) · VASA · doi:10.1024/0301-1526/a001253 · Cited by 1
Laksono, B. B. (2025) · Babali Nursing Research · doi:10.37363/bnr.2025.64479 · Cited by 2
Lockhart, S. M., Puri, A., Zhao, Y., Saudek, V., Gardner, E. J., Kentistou, K. A., Lam, B., Day, F. R., O’Rahilly, S., Perry, J. R. B., et al. (2025) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.125.005233 · Cited by 2
Soares, T. B. D. C., dos Santos, P. L. C., de Moura, R. M. F., Motta‐Santos, D., Gonçalves, R., Delfino-Pereira, P., Pereira, D. N., de Oliveira, C. R. A., Rezende, L. C., Lopes, A. C. S., et al. (2025) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20240211 · Cited by 1
Dietary acid load and its association with all-cause mortality, cardiovascular mortality, and events
Abdollahpour, N., Homayounfar, N., Samadi, N., Farsi, F., Kabourani, A., Hatamzadeh, H., Ferns, G. A., Seifi, N., & Ghayour‐Mobarhan, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-29440-1 · Cited by 1
Alrida, N. A., Albikawi, Z. F., Alotaibi, N., Alkouri, O. A., Saifan, A. R., Jarrah, M., Hammoudeh, A., Khader, Y. S., Alenezy, A. K., Al-Zu'bi, B. M., et al. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1678767 · Cited by 1
Asai, K., Morioka, Y., Ito, R., Komatsubara, M., & Maruoka, H. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03421-2 · Cited by 1
Zhang, Y., Wang, J., Song, K., & Yao, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1671949 · Cited by 1
Aslan, T. V., & Bozkur, B. (2025) · International Journal Of Eurasia Social Sciences · doi:10.70736/ijoess.2031 · Cited by 1
Paquet, S., Delpech, R., Sassenou, J., Kab, S., Zins, M., Ringa, V., & Rigal, L. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-092205 · Cited by 1
Determinants of arterial hypertension in Croatian cohort of general adults: EHUH 2 study
Jelaković, A., Glavić, M. M., Belančić, A., Bilobrk, M., Bilajac, L., Josipović, J., Dumancic, M. B., Stupin, A., Šušnjara, P., Domislovic, M., et al. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000004214 · Cited by 1
Opening Up the Future of Valvular Heart Disease
Messika–Zeitoun, D., Labinaz, M. X., LAU, L. S. W., Tavoosi, A., Grinberg, T., Alfreidi, H., Rashid, M. K., Mulloy, A. J., Thériault-Lauzier, P., Abdel‐Razek, O., et al. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.12.015 · Cited by 2
Association between the Atherosclerotic Modifiable Risk Factor Burden and Coronary Inflammation
Kunimura, A., Tsukamoto, N., Suzuki, W., Kuno, S., Naito, K., Ando, H., Suzuki, Y. A., & Amano, T. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65977 · Cited by 1
Прекина, В. И., Yesina, M. V., Самолькина, О. Г., & Shokina, S. V. (2025) · Innovations in medicine and pharmacy · doi:10.33979/2025-2-3 · Cited by 1
Zhai, L., Wei, J.-L., Huo, R., & You, X. (2026) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2026.01.005 · Cited by 1
Castelnuovo, A. D., & Persichillo, M. (2026) · Bleeding Thrombosis and Vascular Biology · doi:10.4081/btvb.2026.416 · Cited by 1
Adhikari, S., Adhikari, C., Bhatt, P. R., Mishra, R., Adhikari, K., Bhandari, P., Pudasainee, M., & Rana, B. (2026) · BMJ Open · doi:10.1136/bmjopen-2024-096388 · Cited by 1
Moradi, H., Tabibian, S., Pirouz, M. S., Zare–Farashbandi, E., & Sajjadieh, A. (2026) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-026-03626-8 · Cited by 1
Sun, B., Liang, C., Sun, P., Geru, A., Lin, L., Zhao, L., Li, P., Li, Y., Foo, R., Chan, M. Y., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf784.1956 · Cited by 1
Ernst, L., Wallbach, M., Zander, W., Koziolek, M. J., Mader, N., Hoffmann, F., Ulbrich-Dafsari, L., Wienemann, H., Baldus, S., Reuter, H., et al. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004270 · Cited by 3
Pérez-Miguel, E., & Trias‐Llimós, S. (2026) · SSM - Population Health · doi:10.1016/j.ssmph.2026.101904 · Cited by 1
Squirrell, D., Nielsen, C., Vaghefi, E., An, S., Moghadam, S., Yang, S., Xie, L., Rahimi, A., Durbin, M. K., Hou, H., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-41465-8 · Cited by 3
Smolderen, K. G. E., Mena‐Hurtado, C., Divino, V. M., Zhao, Z., Chen, Y., Boland, J., Chao, A., Song, J., Smolarz, B. G., Knop, F. K., et al. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101521 · Cited by 2
Acute hot‐water immersion augments the diastolic blood pressure nocturnal dip in healthy adults
Leaney, S. F., Ponce, F. A. F., Owen, T. F., Harvey, B. L., Davies‐Wilson, O. N., Brand, O. M. A., Coombs, G. B., Moore, J. P., & Oliver, S. J. (2026) · Experimental Physiology · doi:10.1113/ep093583 · Cited by 1
Data Resource Profile: Linking nationwide health and social registries in Estonia (BIG-HEART)
Loo, L., Umov, N., Oja, M., Reisberg, S., Uusküla, A., Kolde, R., & Tillmann, T. (2026) · International Journal of Epidemiology · doi:10.1093/ije/dyag027 · Cited by 1
Møen, E. N., Bjørk, M.-H., Gilhus, N. E., Daltveit, D. S., Contreras, D., Hagen, K., Jayaraman, M., Khanevski, A. N., Meisingset, T. W., Stubberud, A., et al. (2026) · Cephalalgia · doi:10.1177/03331024261428583 · Cited by 1
Singh, R., Chaturvedi, B., Bareth, H., Raj, P., Charan, S. S., Sharma, A., Singh, M., Nathiya, D., & Tomar, B. S. (2026) · Current Cardiology Reviews · doi:10.2174/011573403x421697251125102923 · Cited by 1
Moreno-Herráiz, N., Bohn, L., Otero-Luis, I., Cavero‐Redondo, I., Zornoza-González, E., Escobar-Molina, A., & Saz‐Lara, A. (2026) · Applied Sciences · doi:10.3390/app16062951 · Cited by 1
Jin, M., Kim, Y. J., & Song, C. (2026) · Life · doi:10.3390/life16030508 · Cited by 1
“Covariates included age, sex, hypertension, diabetes mellitus, heart failure, prior stroke or transient ischemic attack, and dyslipidemia, selected based on their established relevance as cardiovascular risk factors [16,17].”
Hu, T., Chen, R., Gu, Y., Yu, C., Liu, X., & Zhang, X. (2026) · Journal of Global Health · doi:10.7189/jogh.16.04107 · Cited by 1
Долгалев, И. В., Ivanova, A. Y., Sarkisova, O. L., & Demidova, A. D. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2026-6328 · Cited by 1
Lee, H., Kang, E., Rhee, T., Park, J. H., Kahng, J. Y., Lee, S., Kim, S., & Choi, S. (2026) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2026.101844 · Cited by 1
Castellanos, Á. M. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014539 · Cited by 1
Nutrients in cardiology: a review. Part 1
Галенко, А. С., & Bulaeva, S. P. (2026) · Clinical nutrition and metabolism · doi:10.17816/clinutr701894 · Cited by 1
Lim, L.-H., Lau, E. S. H., Lui, J. N. M., Ji, L., Unnikrishnan, A. G., Sirinvaravong, S., Chan, S. P., Lim, S. K., Luk, A. O. Y., & Chan, J. C. N. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70755 · Cited by 1
Beyond Fasting Lipids: Nutritional and Clinical Perspectives on Postprandial Triglycerides
Pătru, O., Păunescu, A., Enache, B., Luca, S. A., Văcărescu, C., Ciornei, A.-I., Cozma, D. C., Bena, A., Luca, C. T., & Crișan, S. (2026) · Nutrients · doi:10.3390/nu18081222 · Cited by 1
Relationship between cardiac troponin and myocardial infarction: a bibliometric analysis
Yin, S., Wang, J., & Shi, Y. (2026) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-026-04068-y · Cited by 1
Kumboyono, K., Chomsy, I. N., Tjahjono, C., Kumala, Y. R., & Wihastuti, T. A. (2026) · Vascular Health and Risk Management · doi:10.2147/vhrm.s589069 · Cited by 3
Martin, S., Aberle, J., Duerschmied, D., Grond, M., Lehrke, M., Tröbs, S., Schultze, M., Kossack, N., Richter, L. M., & Gabler, M. (2026) · BMC Health Services Research · doi:10.1186/s12913-026-14428-y · Cited by 1
Hong, J., Oh, M. J., Kim, B., Lee, S., Choi, Y. J., Han, K., & Cho, S. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15093484 · Cited by 1
“First, owing to the retrospective nature of the study, we could not control for confounders such as smoking [23], alcohol consumption [24], obesity [23], physical inactivity [25], poor dietary habits [26], and comorbidities, including impaired fasting glucose [27,28], which are the known risk…”
Okita, S., Saito, Y., Yaginuma, H., Hashimoto, O., Sato, T., Kitahara, H., & Kobayashi, Y. (2026) · JACC Asia · doi:10.1016/j.jacasi.2026.03.030 · Cited by 1
Host–Microbiota Metabolic Interactions in Atherosclerosis: Oral, gut, and Blood Perspectives
Khan, I., Irfan, M., Bacha, A. S., Khan, I., Ali, Y., & Zhiqiang, L. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11054-2 · Cited by 1
Zheng, F., Chen, Y., Xue, G., Xu, J., Wang, Z., Yang, G., Liu, G., Lei, M., Cheng, P., Hao, Y., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.05.021 · Cited by 2
Increased mortality in polycystic ovary syndrome— a cohort study
Piltonen, T., Koskenkari, N. V. S., Koivuaho, E., Morin-Papunen, L. C., Hurskainen, E., Gissler, M., Arffman, R. K., & Ollila, M. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag080 · Cited by 1
Stabellini, N., Nahle, T., Shah, V., Kollapaneni, S. S., Makram, O. M., Cullen, J., Weintraub, N. L., Kunhiraman, H. H., Swami, U., Mahmoudi, M., et al. (2026) · JCO Oncology Practice · doi:10.1200/op-26-00131 · Cited by 1
Sawayama, Y., Harada, A., Takashima, N., Yamamoto, T., Higo, Y., Takabayashi, K., Shioyama, W., Fujii, T., Tanaka-Mizuno, S., Kita, Y., et al. (2026) · European Heart Journal Open · doi:10.1093/ehjopen/oeag094 · Cited by 1
Ohlrogge, A. H., Xu, X., Goodman, A., Jennings, G., Murphy, L., Nelson, M. R., Sharman, J. E., Tassie, R., Schlaich, M. P., & Schutte, A. E. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004358 · Cited by 1
“for cardiovascular diseases (CVD) and premature death in Australia [1,2].”
Tokcan, M., Wolter, F. D., Hohl, M., Fries, P., Kessler, T., Kulenthiran, S., & Böhm, M. (2026) · Clinical Research in Cardiology · doi:10.1007/s00392-026-02949-9 · Cited by 1
Ulrich, J., Jäggi, L., Rüfli, D., & Fuhrimann, S. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05967-7 · Cited by 1
Sinning, D., & Landmesser, U. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag456 · Cited by 1
Sutin, A. R., Zavala, D. V., Milad, E., Stéphan, Y., Karaköse, S., Brown, J., Terracciano, A., & Luchetti, M. (2026) · Psychological Medicine · doi:10.1017/s0033291726104863 · Cited by 1
“Likewise, hypertension, diabetes, and obesity are associated with mortality risk (Magnussen et al., 2023), and individuals higher in purpose are less likely to have these conditions (Hafez et al., 2018; Kim, Delaney, & Kubansky, 2019).”
Zhang, K., Fan, Y., & Wang, Y. (2026) · Journal of International Medical Research · doi:10.1177/03000605261465295 · Cited by 1
Cardiovascular risk in inflamed Danish women and men without standard modifiable risk factors
Nordestgaard, A. T., Ridker, P. M., & Nordestgaard, B. G. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag349 · Cited by 1
Incretin-Based Therapies, Obesity-Associated Inflammation, and Atherosclerotic Cardiovascular Risk
Kafol, J., Jug, B., & Fras, Z. (2026) · Cells · doi:10.3390/cells15141293 · Cited by 1
Candelaria, D., Atkins, T., Briffa, T. G., & Redfern, J. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag401 · Cited by 1
Fuchs, A., Kühl, J. T., Sigvardsen, P. E., Afzal, S., Pham, M. H. C., Nordestgaard, B. G., Køber, L., & Kofoed, K. F. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag612 · Cited by 1
Dyslipidaemia and hepatic steatosis: mechanisms and implications for lipid-lowering therapy
Averna, M., Hussain, M. M., & Norata, G. D. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01336-1 · Cited by 1
Guo, X., Zhu, Y., Li, Y., Qiu, S., Yang, J., Li, C., Zhu, Y., Zhong, J., Zhang, J., Zhou, C., et al. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag418 · Cited by 1
Torroba, S., Bielsa, H., Venturini, N. I., Requejo, M., Arilla, J., & Verges, M. P. (2026) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2026.79 · Cited by 1
Suzuki, Y., Nishikawa, M., Kaneko, H., Okada, A., Ko, T., Fujiu, K., Takeda, N., Morita, H., Nakagawa, N., Azegami, T., et al. (2026) · Hypertension Research · doi:10.1038/s41440-026-02801-7 · Cited by 1
The histone deacetylase family in health and disease
Wen, R., Yang, Y., Zhang, T., Zhang, S.-Y., Yang, X.-R., Zhang, L.-Y., Hao, P.-H., Zheng, Y., Ni, Y., & Zhang, T. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02764-8 · Cited by 2
Gual, C. V., Mautino, G. B., Perea, D. N., Lobos, R. V., Neculhueque-Zapata, X., Flores-González, E., Ojeda, C. N., & Medina1, M. R. (2026) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2026.86 · Cited by 1
Campbell, C., Mugisha, J. O., Kimono, B., Waddilove, E., Makanga, R., Wang, T., Muzaale, F. N., Seeley, J., Nyirenda, M. J., Matthews, P. C., et al. (2026) · BMJ Public Health · doi:10.1136/bmjph-2025-004426 · Cited by 1
Intérêt d'un observatoire de l'infarctus du myocarde des femmes de moins de 50 ans : étude WAMIF
Manzo‐Silberman, S., & Montalescot, G. (2023) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2023.101691 · Cited by 1
Statine: Nebenwirkungen – alternative Therapieoptionen
Makhmudova, U., & Weingärtner, O. (2024) · Die Kardiologie · doi:10.1007/s12181-024-00669-w · Cited by 1
Sathish, T., Sasikumar, M., Demissie, G. D., Pramodkumar, T. A., Oldenburg, B. F., & Oommen, A. M. (2024) · Journal of Diabetology · doi:10.4103/jod.jod_104_23 · Cited by 1
Carrero, R. S. D. V., Blanco, A., Daimiel, L., Blanco, M. J., Segovia, R. C., de la Garza, R. G., & Martínez‐Urbistondo, D. (2024) · Biomedicines · doi:10.3390/biomedicines12030692 · Cited by 1
Tobacco smoking, e-cigarette and thyroid: what are the risks of thyroid disorders
Михайловна, Б. И., Shugurova, E. S., Korchagina, M. O., Borkhoeva, T. N., & Шеремета, М. С. (2024) · Clinical and experimental thyroidology · doi:10.14341/ket12776 · Cited by 1
Rahimi, R., Masoumi, S., Badali, A., Jafari, N., Heidari-Soureshjani, S., & Sherwin, C. M. T. (2024) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/011871529x298791240607041246 · Cited by 1
Mattos, A. J. C., Avezum, Á., França, J. Í. D., Izar, M. C. D. O., Ferreira, J. F. M., Drager, L. F., Saraiva, J. F. K., & Fonseca, H. A. R. (2024) · Cadernos de Saúde Pública · doi:10.1590/0102-311xen234522 · Cited by 1
Uncu, H., Badak, T. O., Uçak, H. A., Cereb, F., Çakallıoğlu, A., & Yıldırım, A. (2024) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_827_23 · Cited by 1
Mohammedi, K., Pigeyre, M., Bosch, J., Yusuf, S., & Gerstein, H. C. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02383-z · Cited by 1
van Schalkwyk, C., van Zyl, B. C., Herbst, P. G., & Ackermann, C. (2024) · Pan African Medical Journal · doi:10.11604/pamj.2024.49.15.44617 · Cited by 1
Therapeutic Strategies to Prevent Recurrent Stroke
Camafort, M., Yang, E., Ponte, C. I., & Coca, A. (2024) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-64928-8_15 · Cited by 1
Rapid Lifestyle Recommendations to Improve Urologic, Heart and Overall Health
Moyad, M. A. (2024) · Current Urology Reports · doi:10.1007/s11934-024-01246-0 · Cited by 2
Mosteiro-Miguéns, D. G., Zapata‐Cachafeiro, M., Novío, S., Pérez, N. V., Alfonso-González, T., & Rodríguez-Fernández, A. (2024) · Family Practice · doi:10.1093/fampra/cmae056 · Cited by 1
Microbiota and the Cardiovascular System
Lorenzo, Ó., Lumpuy‐Castillo, J., Espadas, C., Parascinet, O., & Martínez-Albaladejo, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-65650-7_7 · Cited by 1
Cui, H., Chen, Y., & Zhao, Z. (2024) · Hepatology International · doi:10.1007/s12072-024-10745-8 · Cited by 1
Risk factors for cardiovascular diseases in taxi drivers in Tabriz metropolis
Saadati, M., Naghizad, M. B., Yazdani, M., & Harzand-Jadidi, S. (2024) · Medical Journal of Tabriz University of Medical Sciences and Health Services · doi:10.34172/mj.025.33579 · Cited by 1
Urbonas, G., Šileikienė, L., Valius, L., Grigalė, E., Kaupas, V., Juška, T., Vėbraitė, G., & Grabauskytė, I. (2024) · Medicina · doi:10.3390/medicina60121963 · Cited by 2
“Dyslipidemia, hypertension, smoking, overweight, and diabetes are the modifiable CVD risk factors, accounting together for more than 50% of CVD cases and 20% of deaths from any cause [3].”
Михайловна, Ч. Е., Минувалиевна, Х. Н., Grzhibovsky, A. M., & Bogdanova, A. I. (2024) · Physical and rehabilitation medicine medical rehabilitation · doi:10.36425/rehab637339 · Cited by 1
Kwak, H. S., Kim, H. C., Koo, H. J., Lee, S., Lee, P. H., & Kim, T. O. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03554-8 · Cited by 1
Zhang, Y., Wei, J., Chen, S., Benmarhnia, T., Zhang, K., Wang, X., Deng, X., Gu, H., Lin, Z., Qu, Y., et al. (2025) · Sustainable Cities and Society · doi:10.1016/j.scs.2025.106293 · Cited by 1
Zou, S., Zhang, Y., He, X., Cheng, J., Wang, S., Xiong, Y., Peng, Z., Ao, X., & Yuan, Q. (2025) · Scientific Reports · doi:10.1038/s41598-025-91731-4 · Cited by 1
Damiri, B., Abdul‐Hafez, H. A., & Saifi, M. (2025) · Pediatric Obesity · doi:10.1111/ijpo.70042 · Cited by 1
Lifetime Exposure to Violence and Early Cardiometabolic Risk Factors in a Healthy Swedish Cohort
Lynch, R., Aspelund, T., Fang, F., Bergstedt, J., Hauksdóttir, A., Arnberg, F. K., Hrafnkelsdóttir, Þ. J., Pedersen, N. L., & Valdimarsdóttir, U. A. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.123.032827 · Cited by 1
Drexl, K., Urben, S., Plessen, K. J., & Glaus, J. (2025) · JMIR Research Protocols · doi:10.2196/70990 · Cited by 2
Ejaz, Z., Mahmud, M. R., Asim, M., Khan, N., & Gulzar, H. (2026) · Life and Science · doi:10.37185/lns.1.1.1097 · Cited by 1
Loizidou, E. M., Simistiras, A., Barmpounakis, P., Glentis, S., Dimopoulos, A. C., Anezaki, M., Kontoyiannis, I., Demiris, N., Rouskas, P., Scarmeas, N., et al. (2023) · medRxiv · doi:10.1101/2023.05.17.23290094 · Cited by 1
Mendes, T. B., & Bittencourt, M. S. (2023) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.123.016079 · Cited by 1
Editorial: Ozone-mediated lumbar renal artery denervation – Another arrow in the quiver?
Götzinger, F., & Mahfoud, F. (2024) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2024.05.034 · Cited by 1
Vaghefi, E., An, S., Moghadam, S., Yang, S., Xie, L., Durbin, M. K., Hou, H., Weinreb, R. N., Squirrell, D., & McConnell, M. V. (2024) · medRxiv · doi:10.1101/2024.07.18.24310670 · Cited by 1
Prognostic Value of Cardiovascular Biomarkers—Reply
Neumann, F., Twerenbold, R., & Ojeda, F. (2024) · JAMA · doi:10.1001/jama.2024.16525 · Cited by 1
Fang, C., Qi, X., Yuan, T., Zhu, Z., Li, J., Zhang, Q., Jia, J., & Sun, J. (2025) · Research Square · doi:10.21203/rs.3.rs-5704576/v1 · Cited by 1
Cancer survivorship and functional health: what we need to address in an aging cancer population
Mehnert-Theuerkauf, A., Dalton, S. O., & Johansen, C. (2025) · Acta Oncologica · doi:10.2340/1651-226x.2025.43076 · Cited by 1
Editorial: Gut microbiota-derived metabolites and cardiovascular diseases
Cui, X. B., Li, J., & Yang, T. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1661489 · Cited by 1
Kimura, R. (2026) · Cardiology Journal · doi:10.5603/cj.110388 · Cited by 1
Sun, D., Katare, R., Sethu, P., Cheng, P., & Fan, Y. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1371074
Reliability, validity, and utility of tests and scores
Hoffmann, A. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad345
Filipiak, K. J., Barrios, V., Ferri, C., Fozilov, K. G., Castro, S. J. F., Kuzior, A., Martínez-Martín, F. J., Mullabaeva, G., Nguyen, L. H., Nizamov, U. I., et al. (2023) · Cardiology Journal · doi:10.5603/cj.96912
Metadata
- Authors
- The Global Cardiovascular Risk Consortium
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- The Global Cardiovascular Risk Consortium
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-10-05
- Volume
- 389
- Issue
- 14
- Pages
- 1273-1285
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC10589462
- OpenAlex
- W4386194106
- Cited by
- 909
- References
- 35
- Citations by year
- 2026: 285 · 2025: 359 · 2024: 242 · 2023: 23
- FWCI
- 47.54
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
- Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
- PubMed Central (acceptedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lithuanian University of Health Sciences (submittedVersion, cc-by)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- HAL (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Duo Research Archive (University of Oslo) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- European Union AFFECT-EU (Horizon 2020, No. 847770)
- German Center for Cardiovascular Research (not applicable)
- European Union MORGAM (Biomed, BMH4-CT98-3183)
- European Union GenomEUtwin (FP5, QLG2-CT-2002-01254)
- European Union ENGAGE (FP7, HEALTH-F4-2007-201413)
- European Union CHANCES (FP7, HEALTH-F3-2010-242244)
- European Union BiomarCaRE (FP7, HEALTH-F2-2011-278913)
- European Union euCanSHare (Horizon 2020, No. 825903)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- modifiable risk factors, cardiovascular disease, all-cause mortality, population attributable fraction, body mass index, systolic blood pressure, non-HDL cholesterol, smoking, diabetes mellitus, sex differences, regional variation, global cardiovascular risk, cohort studies, cardiovascular disease incidence, women's health
- MeSH terms
- Heart Disease Risk Factors, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Risk Factors, Smoking, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.